Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2022-11-02 00:00:00 ET · period of report 2022-10-31 · accession 0000899243-22-034759 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-02 | 2022-10-31 | BEAM | Evans John M. | CEO, Dir | S - Sale | $46.30 | -30.0K | 1.07M | -3% | -$1.39M |
| MI | 2022-11-02 | 2022-10-31 | BEAM | Evans John M. | CEO, Dir | S - Sale | $46.36 | -20.0K | 118.0K | -14% | -$927.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-31 | S | D | 11,756 | $46.88 | 1,061,429 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.57 to $47.52, inclusive. |
| 2 | Common | Common Stock | 2022-10-31 | S | D | 2,188 | $47.91 | 103,000 | I | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.57 to $48.40, inclusive. |
| 3 | Common | Common Stock | 2022-10-31 | S | D | 8,235 | $46.91 | 105,188 | I | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.57 to $47.555, inclusive. |
| 4 | Common | Common Stock | 2022-10-31 | S | D | 4,569 | $46.19 | 113,423 | I | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $45.57 to $46.56, inclusive. |
| 5 | Common | Common Stock | 2022-10-31 | S | D | 5,008 | $44.93 | 117,992 | I | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $44.48 to $45.445, inclusive. |
| 6 | Common | Common Stock | 2022-10-31 | S | D | 2,909 | $47.89 | 1,058,520 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.68 to $48.17, inclusive. |
| 7 | Common | Common Stock | 2022-10-31 | S | D | 7,567 | $44.92 | 1,080,953 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $44.48 to $45.445, inclusive. |
| 8 | Common | Common Stock | 2022-10-31 | S | D | 7,768 | $46.19 | 1,073,185 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $45.57 to $46.56, inclusive. |